BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)
Go back to BMO Capital Positive on Abbvie (ABBV) Humira Win Versus Amgen (AMGN)| AbbVie (NYSE: ABBV) | Delayed: 262.82 +2.89 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $259.93 | 52 Week High | $68.12 | |||
| Open | $259.74 | 52 Week Low | $50.71 | |||
| Day High | $264.06 | P/E | 57.01 | |||
| Day Low | $257.87 | EPS | $4.61 | |||
| Volume | 6,145,302 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 403.04 -4.23 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $407.27 | 52 Week High | $176.85 | |||
| Open | $410.16 | 52 Week Low | $133.64 | |||
| Day High | $410.16 | P/E | 60.70 | |||
| Day Low | $401.96 | EPS | $6.64 | |||
| Volume | 3,511,389 | |||||
